Dr. Campos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
925 Gessner
Suite 600
Houston, TX 77024Phone+1 713-827-9525Fax+1 713-827-1380- Is this information wrong?
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Medical Oncology, 1973 - 1975
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1972 - 1975
- Graduate HospitalResidency, Internal Medicine, 1971 - 1972
- Beaumont Hospital, Grosse PointeInternship, Transitional Year, 1970 - 1971
- Cayetano Heredia UniversityClass of 1969
Certifications & Licensure
- TX State Medical License 1975 - 2024
- WA State Medical License 1973 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
Publications & Presentations
PubMed
- 47 citationsA Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellul...Devalingam Mahalingam, Julio Peguero, Putao Cen, Sukeshi Patel Arora, John Sarantopoulos, Julie Rowe, Victoria Allgood, Benjamin Tubb, Luis T. Campos> ;Cancers. 2019 Jun 17
- 32 citationsA Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic ...Lee S. Schwartzberg, Francis P. Arena, Bryan J. Bienvenu, Edward H. Kaplan, Luis H. Camacho, Luis T. Campos, J. Paul Waymack, Mary Tagliaferri, Michael M. Chen, Dapeng Li> ;Journal of Cancer. 2017 Jul 3
- 8 citationsPhase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced CancerJohn Sarantopoulos, Monica M. Mita, Michael J. Birrer, Lee D. Cranmer, Luis T. Campos, Xiaoping Zhang, Penelope Bristow, Hidekuni Kaito, Vincent Strout, Luis H. Camacho> ;Targeted Oncology. 2016 Jun 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- HCA Houston Healthcare Medical CenterHouston, Texas
- Houston Methodist Continuing Care HospitalKaty, Texas
- East Houston Regional Medical CenterHouston, Texas
- Memorial Hermann Katy HospitalKaty, Texas
- Memorial Hermann Memorial City Medical CenterHouston, Texas
- Memorial Hermann Sugar Land HospitalSugar Land, Texas
- St. Joseph Medical CenterHouston, Texas
- St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas
- Memorial Hermann - Texas Medical CenterHouston, Texas
- Memorial Hermann Physician NetworkHouston, Texas
- Houston Methodist West HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: